Matthew Rees
Direktor/Vorstandsmitglied bei COPPER ROAD RESOURCES INC.
Vermögen: 3 135 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Matthew Rees
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Precious Metals | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Matthew Rees
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| GENSOURCE POTASH CORPORATION | Chemicals: Agricultural | Director/Board Member Director of Finance/CFO | |
| DSA Corporate Services, Inc. | President Director/Board Member | ||
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Marrelli & Drake Corporate Services | Corporate Officer/Principal Corporate Officer/Principal | ||
| ENERGY FUELS INC. | Other Metals/Minerals | Chairman Director/Board Member | |
| ODYSSEY RESOURCES LIMITED | Precious Metals | Director/Board Member Director/Board Member | |
| G2 GOLDFIELDS INC. | Precious Metals | Corporate Secretary Director of Finance/CFO | |
| BE RESOURCES INC. | Other Metals/Minerals | Director/Board Member Chief Executive Officer | |
| York University | College/University | Undergraduate Degree Undergraduate Degree | |
| GPM METALS INC. | Other Metals/Minerals | Corporate Secretary Director of Finance/CFO | |
| REVIVAL GOLD INC. | Precious Metals | Director of Finance/CFO | |
| GLOBEX MINING ENTERPRISES INC. | Precious Metals | Director of Finance/CFO | |
| ARANJIN RES | Other Metals/Minerals | Director of Finance/CFO | |
| DYNACERT INC. | Trucks/Construction/Farm Machinery | Director of Finance/CFO | |
| NEW FRONTIER VENTURES INC. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| SABRE GOLD MINES CORP. | Precious Metals | Director of Finance/CFO | |
| BLUE LAGOON RESOURCES INC. | Other Metals/Minerals | Director of Finance/CFO | |
| PTX METALS INC. | Precious Metals | Director of Finance/CFO | |
| SKYLIGHT HEALTH GROUP INC. | Medical/Nursing Services | Director of Finance/CFO | |
| AYR WELLNESS INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
79North Ltd.
 79North Ltd. Precious MetalsNon-Energy Minerals 79North Ltd. is an exploration stage company, which engages in the acquisition, exploration and development of mineral resource properties. It holds interest in Nassau, Sela Creek and Sandpiper Gold projects. The company was founded on August 15, 2016 and is headquartered in Toronto, Canada. | Precious Metals | Director of Finance/CFO | |
| TINTINA MINES LIMITED | Other Metals/Minerals | Director/Board Member | |
| ESKAY MINING CORP. | Precious Metals | Director of Finance/CFO | |
| MANITOU GOLD INC. | Precious Metals | Director of Finance/CFO | |
| Institute of Chartered Secretaries & Administrators of Canada | Corporate Officer/Principal | ||
| DEVERON CORP. | Packaged Software | Director of Finance/CFO | |
| REVIVE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
Revive Therapeutics, Inc.
 Revive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Revive Therapeutics Ltd., Revive Therapeutics, Inc. is a specialty life sciences company based in North York, CA. The company focuses on the research and development of therapeutics for rare disorders and infectious diseases. Revive Therapeutics' cannabinoid pharmaceutical portfolio focuses on rare inflammatory areas such as liver disease. Revive Therapeutics was acquired by Mercury Capital II Ltd. on January 06, 2014 for $4.67 million. The Canadian company was granted FDA orphan drug status designation for the use of CBD to treat auto-immune hepatitis and ischemia and reperfusion injury from organ transplantation. The company is also exploring the use of bucillamine for the potential treatment of infectious diseases, including COVID-19. The company was founded by Fabio Chianelli. Revive recently acquired Psilocin Pharma Corp. to advance psilocybin-based therapeutics in various diseases and disorders. | Pharmaceuticals: Major | Director of Finance/CFO | |
| PHIVIDA HOLDINGS INC. | Pharmaceuticals: Other | Director of Finance/CFO | |
| OLIVE RESOURCE CAPITAL INC. | Precious Metals | Director of Finance/CFO | |
| OUTDOORPARTNER MEDIA CORPORATION | Advertising/Marketing Services | Director/Board Member | |
| MARTINA MINERALS CORP. | Precious Metals | Director of Finance/CFO | |
| INVENTUS MINING CORP. | Precious Metals | Director of Finance/CFO | |
| PINETREE CAPITAL LTD. | Financial Conglomerates | Director of Finance/CFO | |
| MEGA URANIUM LTD. | Other Metals/Minerals | Director of Finance/CFO | |
| SINTANA ENERGY INC. | Other Metals/Minerals | Director of Finance/CFO | |
| ROYAL STANDARD MINERALS INC. | Precious Metals | Chief Executive Officer | |
| MAGNA GOLD CORP. | Precious Metals | Director of Finance/CFO |
Statistik
International
| Kanada | 47 |
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
| Mongolei | 2 |
Sektoral
| Non-Energy Minerals | 28 |
| Finance | 9 |
| Health Technology | 5 |
| Commercial Services | 4 |
| Process Industries | 2 |
Operativ
| Director of Finance/CFO | 94 |
| Director/Board Member | 59 |
| Corporate Secretary | 39 |
| Independent Dir/Board Member | 25 |
| President | 18 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Carmelo Marrelli | 106 |
| Mark Goodman | 27 |
| Shaun Drake | 25 |
| James Bovaird | 23 |
| Eric Szustak | 14 |
| John Timmons | 6 |
| Michael Waring | 3 |
- Börse
- Insiders
- Matthew Rees
- Unternehmensverbindungen
